Compounds > diamminediaqua platinum(ii)
Page last updated: 2024-09-04

diamminediaqua platinum(ii) and Lymphoma

diamminediaqua platinum(ii) has been researched along with Lymphoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arnon, R; Haimovich, J; Pauzner, R; Schechter, B; Wilchek, M1
Arnon, R; Rosing, MA; Schechter, B; Wilchek, M1

Other Studies

2 other study(ies) available for diamminediaqua platinum(ii) and Lymphoma

ArticleYear
Selective cytotoxicity against tumor cells by cisplatin complexed to antitumor antibodies via carboxymethyl dextran.
    Cancer immunology, immunotherapy : CII, 1987, Volume: 25, Issue:3

    Topics: Animals; Antibodies, Anti-Idiotypic; Antibodies, Neoplasm; B-Lymphocytes; Cisplatin; Dextrans; DNA Replication; Immunoglobulin G; Immunoglobulin Idiotypes; Immunoglobulin M; Lymphoma; Mice; Receptors, Antigen, B-Cell; Tumor Cells, Cultured

1987
Blood levels and serum protein binding of cis-platinum(II) complexed to carboxymethyl-dextran.
    Cancer chemotherapy and pharmacology, 1989, Volume: 24, Issue:3

    Topics: Animals; Blood Proteins; Cisplatin; Dextrans; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Lymphoma; Mice; Mice, Inbred BALB C; Molecular Weight; Protein Binding; Time Factors; Tumor Cells, Cultured

1989